data biospace - Robuta Search

https://www.biospace.com/drug-development/aacr-2026-moderna-revolution-zymeworks-and-beone-showcase-new-data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data - BioSpace Apr 21, 2026 - Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer. aacr 2026 showcase new data biospace moderna revolution https://www.biospace.com/drug-development/alkermes-pushes-narcolepsy-program-to-phase-iii-with-highly-competitive-mid-stage-data Alkermes Pushes Narcolepsy Program to Phase III With ‘Highly Competitive’ Mid-Stage Data - BioSpace Nov 13, 2025 - Alixorexton’s Phase II performance sets it up for late-stage success, according to analysts at Truist Securities. Alkermes expects to launch a global... phase iii mid stage data biospace alkermes pushes https://www.biospace.com/drug-development/maze-loses-nearly-a-third-of-market-cap-on-mixed-midstage-kidney-drug-data Maze Loses Nearly a Third of Market Cap on Mixed Midstage Kidney Drug Data - BioSpace Mar 26, 2026 - Besting Vertex Pharmaceuticals’ kidney disease asset wasn’t enough to impress Wall Street, which appears to be “getting hung up” with the broad population data... loses nearly market cap drug data maze third https://www.biospace.com/drug-development/wave-stock-cut-in-half-on-underwhelming-higher-dose-obesity-data Wave Stock Cut in Half on Underwhelming Higher Dose Obesity Data - BioSpace Mar 26, 2026 - While participants on a lower dose of Wave Life Sciences’ RNA therapy lost 5.3% total fat at the six-month mark, those receiving the higher dose saw a less... obesity data wave stock cut half https://www.biospace.com/genentech-to-present-positive-data-for-agressive-lymphoma-antibody-at-asco Genentech Announces Optimistic Data in Aggressive DLBCL - BioSpace May 27, 2022 - Genentech announced new data related to its investigational CD20xCD3 T-cell engaging bispecific antibody intended to treat relapsed or refractory diffuse large... genentech announces optimistic data aggressive